CIK 0001415397 · Non-accelerated filer<br>Smaller reporting company
Raphael Pharmaceutical Inc.
Sign in to watch- Ticker
- RAPH
- Exchange
- OTC
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 260204284
- Phone
- 702-442-1166
- Business address
- SUITE 105 - 5348 VEGAS DR., LAS VEGAS, NV, 89108
- Former names
- Easy Energy Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-20 | Louria Hayon Igal Chief Technology Officer | Option exercise | +350,000 | $0.01 | $4K | 1,349,000 |
| 2025-11-20 | Louria Hayon Igal Chief Technology Officer | Option exercise · Warrants to purchase Common Stock | −350,000 | 0 | ||
| 2025-03-10 | Eliya Yehuda Director | Grant or award · Warrant to purchase Common Stock | +200,000 | 200,000 | ||
| 2025-03-05 | Dhadha Ajay Kumar Director | Grant or award | +350,000 | 351,667 | ||
| 2025-03-05 | Dhadha Ajay Kumar Director | Grant or award · Warrant to purchase Common Stock | +250,000 | 250,000 | ||
| 2025-03-02 | Pilo Shlomo Chief Executive Officer | Grant or award | +200,000 | $0.50 | $100K | 3,983,701 |
| 2025-03-02 | Pilo Shlomo Chief Executive Officer | Grant or award · Warrant to purchase Common Stock | +100,000 | 1,100,000 | ||
| 2023-11-25 | Eliya Yehuda Director | Grant or award | +150,000 | $0.40 | $60K | 352,000 |
| 2023-08-29 | Louria Hayon Igal Chief Technology Officer | Option exercise | +999,000 | $0.01 | $10K | 999,000 |
| 2023-08-29 | Louria Hayon Igal Chief Technology Officer | Option exercise · Warrants to purchase Common Stock | −999,000 | 0 | ||
| 2022-12-05 | Eliya Yehuda Chief Financial Officer | Grant or award · Warrants to Purchase Common Stock | +202,000 | 202,000 | ||
| 2022-12-05 | Pilo Shlomo Chief Executive Officer | Grant or award · Warrants to Purchase Common Stock | +1,000,000 | 1,000,000 | ||
| 2022-12-05 | Press Joseph Director | Grant or award · Warrants to Purchase Common Stock | +105,000 | 105,000 | ||
| 2022-12-05 | Louria Hayon Igal Chief Technology Officer | Grant or award · Warrants to Purchase Common Stock | +999,000 | 990,000 | ||
| 2022-12-05 | Ofir Guy Chief Financial Officer | Grant or award · Warrants to Purchase Common Stock | +1,000,000 | 1,000,000 | ||
| 2022-07-26 | Press Joseph Director | Grant or award | +280,000 | 280,000 | ||
| 2022-07-26 | Ofir Guy Chief Financial Officer | Grant or award | +1,000,000 | 1,266,455 | ||
| 2022-05-12 | Eliya Yehuda Director | Other disposition · Warrant to purchase Common Stock | −202,000 | 0 | ||
| 2010-09-30 | Yanay Elisha Director | Grant or award · Warrant (right to buy) | +4,500,000 | 4,500,000 | ||
| 2010-09-30 | CATELL ROBERT B Director | Grant or award · Warrant (right to buy) | +1,500,000 | 1,500,000 |
Page 1 of 3 · 42 trades